Considering the pro-inflammatory nature of IFNα in SLE and the anti-inflammatory role of IFNβ in MS, specification of the type I IFN response in autoimmune diseases might give new insights into its role in disease pathology and/or its therapeutic potential. Here, IFNA1 is linked to systemic lupus erythematosus.